<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03195244</url>
  </required_header>
  <id_info>
    <org_study_id>AT&amp;ASD</org_study_id>
    <nct_id>NCT03195244</nct_id>
  </id_info>
  <brief_title>Aquatic Therapy and Autism Spectrum Disorders</brief_title>
  <acronym>AT&amp;ASD</acronym>
  <official_title>Aquatic Therapy and Autism Spectrum Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sloan W. Rush, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Panhandle Eye Group, LLP</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of one-on-one versus group-based aquatic therapy on the social
      interactions, behaviors and physical activities of children with autism spectrum disorders
      (ASDs).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2017</start_date>
  <completion_date type="Anticipated">February 12, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in PedsQL Score</measure>
    <time_frame>Baseline and 10 weeks after intervention</time_frame>
    <description>Survey</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>One-on-one Aquatic Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Aquatic Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aquatic Physical Therapy</intervention_name>
    <description>Swim Whisperer's Aquatic Therapy Sessions</description>
    <arm_group_label>One-on-one Aquatic Therapy</arm_group_label>
    <arm_group_label>Group Aquatic Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligibility criteria:

          -  DSM-V diagnosis of Autism Spectrum Disorder or DSM-IV diagnosis of Asperger's syndrome
             or high functioning atypical autism or pervasive development disorder - not otherwise
             specified or else the typical clinical findings and suspicion of an ASD

          -  Treatment na√Øve to prior aquatic therapy

        Exclusion criteria:

          -  Not willing to undergo an investigational treatment

          -  Unable to cooperate well enough to safely participate in aquatic therapy under the
             protocol guidelines

          -  Known allergies to pool chemicals

          -  Other significant co-morbidities which may include (but is not limited to): severe
             cerebral palsy with low motor function, advanced pulmonary disease, home oxygen
             requirement, spina bifida with low motor function, permanent feeding tubes, poorly
             controlled seizure disorder, chronic indwelling urinary catheters or any condition
             causing severe cognitive impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruce Moseley</last_name>
    <phone>806-353-3596</phone>
    <email>bruce@turncenter.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Turn Center</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Moseley</last_name>
      <phone>806-353-3596</phone>
      <email>bruce@turncenter.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Panhandle Eye Group, LLP</investigator_affiliation>
    <investigator_full_name>Sloan W. Rush, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>aquatic therapy, hydrotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

